Susanne M Kremer

Title: Susanne M Kremer: Innovator in Biochemical Synthesis

Introduction

Susanne M Kremer is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of biochemical synthesis, particularly in the production of 1,4-butanediamine. With a total of two patents to her name, her work showcases the intersection of biotechnology and innovation.

Latest Patents

Kremer's latest patents focus on the biochemical synthesis of 1,4-butanediamine. The first patent describes a process for synthesizing 1,4-butanediamine in a microorganism that exhibits an increased level of ornithine decarboxylase activity. This increased activity is achieved through the overexpression of an ornithine decarboxylase encoding gene, which enhances translational and/or transcriptional efficiency. The process involves excreting the produced 1,4-butanediamine into a fermentation broth, from which it is subsequently recovered. The second patent also relates to the biochemical synthesis of 1,4-butanediamine, emphasizing the microorganism's increased activity of N-acetylglutamate formation alongside the enhanced ornithine decarboxylase activity.

Career Highlights

Susanne M Kremer is currently associated with DSM IP Assets B.V., where she continues to advance her research and innovations. Her work has positioned her as a key figure in the field of biochemical engineering, contributing to sustainable and efficient production methods.

Collaborations

Kremer collaborates with notable colleagues, including Katrin Eppelmann and Petrus M M Nossin. These partnerships enhance her research capabilities and foster innovation in her projects.

Conclusion

Susanne M Kremer's contributions to biochemical synthesis exemplify the vital role of inventors in advancing technology. Her patents reflect a commitment to innovation and sustainability in the production of essential compounds.